Skip to main content
. 2013 Jul 23;136(8):2419–2431. doi: 10.1093/brain/awt192

Figure 7.

Figure 7

Tyrosine hydroxylase immunoreactivity (TH-ir) decreases in SN region with the progression of disease. Representative nigra sections from a control (A) and patients with Parkinson’s disease, with a disease duration of 1 year (B), 4 years (C), 5 years (D), 7 years (E), 11 years (F), 14 years (G), 15 years (H), 18 years (I), 19 years (J), 22 years (K) and 27 years (L). Scale bar in L = 100 µm.